All Comments by Alexei Koudinov

  1. Immune hyporesponsiveness to amyloid beta-peptide in amyloid precursor protein transgenic mice: implications for the pathogenesis and treatment of Alzheimer's disease.
  2. The levels of soluble amyloid beta in different high density lipoprotein subfractions distinguish Alzheimer's and normal aging cerebrospinal fluid: implication for brain cholesterol pathology?
  3. Plaque-associated disruption of CSF and plasma amyloid-beta (Abeta) equilibrium in a mouse model of Alzheimer's disease.
  4. Chronic nicotine treatment reduces beta-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw).
  5. Nordihydroguaiaretic acid potently breaks down pre-formed Alzheimer's beta-amyloid fibrils in vitro.
  6. Platelets in atherosclerosis: a new role for beta-amyloid peptide beyond Alzheimer's disease.
  7. Essential role for cholesterol in synaptic plasticity and neuronal degeneration.
  8. CNS synaptogenesis promoted by glia-derived cholesterol.
  9. Immunotherapy with beta-amyloid for Alzheimer's disease: a new frontier.
  10. Clearing the brain's amyloid cobwebs.
  11. Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid beta-peptide.
  12. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo.
  13. Predicting the failure of amyloid-beta vaccine.
  14. Diagnosing the Early Stages of Alzheimer's